Combining baseline clinical descriptors and real-time response to therapy: The incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarction

American Heart Journal

Volumn 147, Issue 4, 2004, Pages 698-704

  Maas, Arthur C P ^a,e   Wyatt, Christina M ^a   Green, Cynthia L ^a   Wagner, Galen S ^a   Trollinger, Kathleen M ^a   Pope, James E ^a   Langer, Anatoly ^b   Armstrong, Paul W ^c   Califf, Robert M ^a   Simoons, Maarten L ^d   Krucoff, Mitchell W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e ISALA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTITHROMBOCYTIC AGENT; EPTIFIBATIDE; STREPTOKINASE; THROMBIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CONVALESCENCE; DEVICE; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG RESPONSE; DRUG USE; FEMALE; HEART RATE; HEART REINFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; ST SEGMENT ELEVATION; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE AGGREGATION; THROMBOSIS; THROMBUS; UNIVERSITY;

AGED; BLOOD PRESSURE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RECURRENCE; RISK;

EID: 3142615808     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2003.08.014     Document Type: Article

References (27)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 343:1994;311-322
2. Vermeer F. Simoons ML. Bar FW, et al. Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase [published erratum appears in Circulation 1987;75:394]? Circulation 1986;74:1379-89
3. Lee K.L., Woodlief L.H., Topol E.J., et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Circulation. 91:1995;1659-1668
4. Simoons M.L., Arnold A.E.R. Tailored thrombolytic therapy A perspective. Circulation. 88:1993;2556-2564
5. Boersma H., Van der Vlugt M.J., Arnold A.E.R., et al. Estimated gain in life expectancy A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction. Eur Heart J. 17:1996;64-75
6. European Secondary Prevention Study Group. Translation of clinical trials into practice A European population based study of the use of thrombolysis for acute myocardial infarction. Lancet. 347:1996;1203-1207
7. Lenderink T., Simoons M.L., Van Es G.A., et al. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. Circulation. 92:1995;1110-1116
8. Simes R.J., Topol E.J., Holmes D.R. Jr, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion Importance of early and complete infarct artery reperfusion. Circulation. 332:1995;1418-1424
9. Krucoff M.W., Croll M.A., Pope J.E., et al. Continuous 12 lead ST segment recovery analysis in the TAMI-7 Study Performance of a non-invasive method for real-time detection of failed myocardial reperfusion. Circulation. 88:1993;437-446
10. Dellborg M., Steg P.G., Simoons M.L., et al. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. Eur Heart J. 16:1995;21-29
11. Klootwijk P., Langer A., Meij S., et al. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. [erratum published in Eur Heart J 1996;17:1451] Eur Heart J. 17:1996;689-698
12. Wall T.C., Califf R.M., Blankenship J., et al. Intravenous fluosol in the treatment of acute myocardial infarction Results of the Thrombolysis and Angioplasty in Myocardial Infarction 9 trial. Circulation. 90:1994;114-120
13. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682
14. O'Connor C.M., Meese R.B., McNulty S., et al. A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction. Am J Cardiol. 77:1996;791-797
15. Ohman E.M., Kleiman N.S., Gacioch G., et al. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with integrilin in acute myocardial infarction Results of a randomized, placebo-controlled, dose ranging trial. Circulation. 95:1997;846-854
16. The PRIME Investigators. Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial. Am Heart J. 143:2002;95-105
17. The PARADIGM Investigators. Enhancement of thrombolysis with concomitant use of the platelet glycoprotein IIb/IIIa inhibitor lamifiban The Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. J Am Coll Cardiol. 32:1998;2003-2010
18. Krucoff M.W., Wagner N.B., Pope J.E., et al. The portable programmable microprocessor-driven real-time 12 lead electrocardiographic monitor A preliminary report of a new device for the non-invasive detection of successful reperfusion or silent coronary reocclusion. Am J Cardiol. 65:1990;143-148
19. Krucoff M.W., Green C.L., Harrell F.E., et al. From signal/ noise to information content/noise. Reconsidering the statistical analysis of continuous ST-segment data streams with gaps Potential optimization of application-specific information content using left, right, and interval censoring. J Electrocardiol. 27:1994;233-237
20. Krucoff MW, Green, CL, Trollinger KM, et al. Angiography: "gold" standard or "tin" standard of reperfusion? A comparison with continuous 12-lead ST-segment recovery for prediction of clinical outcomes after thrombolytic therapy for acute myocardial infarction [abstract]. Circulation 1996;94:I-440
21. Langer A., Krucoff M.W., Klootwijk P., et al. Noninvasive assessment of speed and stability of infarct-related artery reperfusion Results of the GUSTO-I ST segment monitoring study. J Am Coll Cardiol. 25:1995;1552-1557
22. Barbash G.I., Roth A., Hod H., et al. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase Results of the Israeli Study of Early Intervention in Myocardial Infarction. Br Heart J. 64:1990;241-247
23. Schroder R., Wegsneider K., Schroder K., et al. Extent of early ST segment elevation resolution A strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol. 26:1995;1657-1664
24. Shah A., Wagner G.S., Granger C.B., et al. Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis Reexamining the "gold standard" for myocardial reperfusion assessment. J Am Coll Cardiol. 35:2000;666-672
25. Madsen J.K., Grande P., Saunamäki K., et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Circulation. 96:1997;748-755
26. De Winter R.J., Koster R.W., Sturk A., et al. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation. 92:1995;3401-3407
27. Mohler E.R., Ryan T., Segar D.S., et al. Clinical utility of troponin T levels and echocardiography in the emergency department. Am Heart J. 135:1998;253-260